Statement on APVMA relocation decision

25 November 2016 (Canberra)

Today’s announcement by the Deputy Prime Minister that the APVMA will relocate to Armidale as early as March 2017 raises the serious prospect of a critical deterioration of APVMA’s capacity to perform the functions entrusted to it by the Australian people.

“There is a significant, real risk that this move will result in a loss of highly qualified, specialist product risk assessors. This would seriously undermine the agency’s capacity to deliver high quality, science based and predictable product assessments.” said AMA’s Executive Director Mr Ben Stapley.

“Now that the Deputy Prime Minister has announced a March 2017 timeframe for the move, it is critically important that measures be put in place to ensure that assessments for veterinary medicines are not delayed.”

“This would not only impact our members, but hurt veterinarians, farmers and others that benefit from access to veterinary medicines to improve the health and welfare of animals under their care” said Mr Stapley.

“At a time when Australia has an enormous opportunity to exploit new and emerging export markets, it is critical that Australian producers maintain access to the latest medicines to maintain healthy and productive animals. These products will only become more important in the face of more extreme weather and climate conditions. They are essential to maintain and enhance the competitiveness of Australian agriculture.” said Mr Stapley.

Animal Medicines Australia represents importers, manufacturers and registrants of veterinary products designed to improve the health and welfare of Australia’s farm production animals and companion animals.



Ben Stapley

0436 191 011

For a pdf version of this statement, click here.